19712483|t|Weighted gene co-expression network analysis of the peripheral blood from Amyotrophic Lateral Sclerosis patients.
19712483|a|BACKGROUND: Amyotrophic Lateral Sclerosis (ALS) is a lethal disorder characterized by progressive degeneration of motor neurons in the brain and spinal cord. Diagnosis is mainly based on clinical symptoms, and there is currently no therapy to stop the disease or slow its progression. Since access to spinal cord tissue is not possible at disease onset, we investigated changes in gene expression profiles in whole blood of ALS patients. RESULTS: Our transcriptional study showed dramatic changes in blood of ALS patients; 2,300 probes (9.4%) showed significant differential expression in a discovery dataset consisting of 30 ALS patients and 30 healthy controls. Weighted gene co-expression network analysis (WGCNA) was used to find disease-related networks (modules) and disease related hub genes. Two large co-expression modules were found to be associated with ALS. Our findings were replicated in a second (30 patients and 30 controls) and third dataset (63 patients and 63 controls), thereby demonstrating a highly significant and consistent association of two large co-expression modules with ALS disease status. Ingenuity Pathway Analysis of the ALS related module genes implicates enrichment of functional categories related to genetic disorders, neurodegeneration of the nervous system and inflammatory disease. The ALS related modules contain a number of candidate genes possibly involved in pathogenesis of ALS. CONCLUSION: This first large-scale blood gene expression study in ALS observed distinct patterns between cases and controls which may provide opportunities for biomarker development as well as new insights into the molecular mechanisms of the disease.
19712483	74	103	Amyotrophic Lateral Sclerosis	Disease	MESH:D000690
19712483	104	112	patients	Species	9606
19712483	126	155	Amyotrophic Lateral Sclerosis	Disease	MESH:D000690
19712483	157	160	ALS	Disease	MESH:D000690
19712483	538	541	ALS	Disease	MESH:D000690
19712483	542	550	patients	Species	9606
19712483	623	626	ALS	Disease	MESH:D000690
19712483	627	635	patients	Species	9606
19712483	740	743	ALS	Disease	MESH:D000690
19712483	744	752	patients	Species	9606
19712483	979	982	ALS	Disease	MESH:D000690
19712483	1029	1037	patients	Species	9606
19712483	1077	1085	patients	Species	9606
19712483	1214	1225	ALS disease	Disease	MESH:D000690
19712483	1268	1271	ALS	Disease	MESH:D000690
19712483	1351	1368	genetic disorders	Disease	MESH:D030342
19712483	1370	1409	neurodegeneration of the nervous system	Disease	MESH:D009422
19712483	1414	1434	inflammatory disease	Disease	MESH:D007249
19712483	1440	1443	ALS	Disease	MESH:D000690
19712483	1533	1536	ALS	Disease	MESH:D000690
19712483	1604	1607	ALS	Disease	MESH:D000690

